Cargando…

Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia

OBJECTIVES: Febrile neutropenia (FN) is severe and potentially life-threatening in oncologic patients. The objective of this study is to define the factors associated with severe adverse outcomes of pediatric FN. METHODS: A retrospective and prospective descriptive study performed in pediatric patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thangthong, Jutarat, Anugulruengkitt, Suvaporn, Lauhasurayotin, Supanun, Chiengthong, Kanhatai, Poparn, Hansamon, Sosothikul, Darintr, Techavichit, Piti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046322/ https://www.ncbi.nlm.nih.gov/pubmed/33369443 http://dx.doi.org/10.31557/APJCP.2020.21.12.3487

Ejemplares similares

The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
por: Jungrungrueng, Thanyathorn, et al.
Publicado: (2021)

Prenatal Diagnosis Leads to Early Diagnosis of Transfusion-Dependent Thalassemia and Better Growth Outcomes
por: Asawasudsakorn, Natthida, et al.
Publicado: (2021)

A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol
por: Chaweephisal, Phumin, et al.
Publicado: (2021)

KRAS Mutation in Pediatric Intracranial Germ Cell Tumors
por: Khaiman, Chusana, et al.
Publicado: (2022)

Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma
por: Jaruthien, Thitiporn, et al.
Publicado: (2023)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
por: Suwannaying, Kunanya, et al.
Publicado: (2022)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021)

Langerhans Cell Histiocytosis Manifests with Acute Severe Hypernatremia during Hospitalization
por: Takkavatakarn, Kullaya, et al.
Publicado: (2022)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
por: Hodgson-Viden, Heather, et al.
Publicado: (2005)

Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients—A Systematic Review
por: Boeriu, Estera, et al.
Publicado: (2022)

The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study
por: Rujkijyanont, Piya, et al.
Publicado: (2019)

Author Correction: The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

Prevalence of Fungemia in Pediatric Patients with Febrile Neutropenia
por: Meidani, Mohsen, et al.
Publicado: (2018)

All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia
por: Shmuely, Haim, et al.
Publicado: (2023)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

1550. Pediatric Febrile Neutropenia: Does Depth and Duration of Neutropenia at Presentation Predict Outcomes?
por: Alali, Muayad, et al.
Publicado: (2018)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Ambulatory management of low-risk febrile neutropenia in adult oncological patients. Systematic review
por: Forcano-Queralt, Ester, et al.
Publicado: (2023)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Clozapine-Induced Febrile Neutropenia and Cellulitis
por: YAYLACI, Selcuk, et al.
Publicado: (2016)

Timely Assessment and Management of Febrile Neutropenia
por: Viale, Pamela Hallquist
Publicado: (2019)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021)

GCT-13. KRAS MUTATION IN PEDIATRIC INTRACRANIAL GERM CELL TUMORS
por: Khaiman, Chusana, et al.
Publicado: (2022)

Prevention of Emerging Infections in Children
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia()
por: Janssens, Keegan Peter, et al.
Publicado: (2020)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy
por: Lima, Mariana Antunes Faria, et al.
Publicado: (2023)

Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America
por: Melgar, Mario A., et al.
Publicado: (2021)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

Impact of effective prevention and management of febrile neutropenia
por: Krell, D, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lbr4ib8lcaehq01qnnagr1j5rs